Trials / Conditions / Chronic Lymphoid Leukemia in Relapse
Chronic Lymphoid Leukemia in Relapse
3 registered clinical trials studyying Chronic Lymphoid Leukemia in Relapse.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL NCT05360238 | Mustang Bio | Phase 1 / Phase 2 |
| Active Not Recruiting | Belimumab in Patients with Chronic Lymphocytic Leukemia NCT05069051 | University Hospital Tuebingen | Phase 2 |
| Completed | Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL NCT04030195 | Precision BioSciences, Inc. | Phase 1 / Phase 2 |